News
Altasciences has received a sustainability Gold Medal from EcoVadis, placing it in the 96th percentile and among the top 5% ...
Schreiner MediPharm has partnered with Bluesight to launch an RFID-based system for digital inventory control in hospital ...
Spring Bio Solution will offer OneScan to pharmaceutical manufacturers across India, Europe, Singapore, and other key global ...
Nucleus RadioPharma, a contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, has ...
Wegovy is now positioned as the first and only GLP-1 treatment.
FDA states substantial evidence of efficacy was not demonstrated.
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 ...
IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending ...
Developed by Daiichi Sankyo and Merck, it treats patients with Pretreated Extensive-Stage Small Cell Lung Cancer.
Systlmmune and BMS’ ACD treats patients with previously treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer.
In partnership with the University of Oxford’s Pandemic Sciences Institute, the grant will advance oral vaccine delivery.
Precigen, Inc., a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results